Stock Price
38.21
Daily Change
0.74%
Yearly
-38.36%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Daiichi Sankyo 2,835.50 22.00 0.78% -16.77%
Acadia Pharmaceuticals 21.78 0.46 2.16% -58.38%
Alnylam Pharmaceuticals 176.92 -3.36 -1.86% 42.63%
Alexion Pharmaceuticals 182.50 0 0% 70.54%
Amgen 213.53 2.21 1.05% -7.10%
Arena Pharmaceuticals 54.71 2.05 3.89% -20.57%
BioCryst Pharmaceuticals 12.24 0.03 0.25% 68.60%
Biogen 234.72 7.89 3.48% -4.10%
Bluebird Bio 10.00 0.05 0.50% -76.53%
BioMarin Pharmaceutical 88.38 2.26 2.62% 16.05%
Cytokinetics 37.05 -0.42 -1.12% 81.00%
Enanta Pharmaceuticals 74.81 -2.85 -3.67% 75.98%
Esperion Therapeutics 5.87 0.31 5.58% -79.99%
Gilead Sciences 69.71 0.06 0.09% 14.62%
GW Pharmaceuticals 218.96 0 0% 108.53%
Intercept Pharmaceuticals 17.11 0.16 0.94% -48.62%
Incyte Corp 67.33 0.60 0.90% -16.84%
Ionis Pharmaceuticals 32.21 1.64 5.36% -34.24%
Ironwood Pharmaceuticals 11.44 0 0% -3.70%
Karyopharm Therapeutics 7.16 -0.10 -1.38% -53.48%
Novartis 74.82 -0.03 -0.04% -7.96%
Puma Biotechnology 3.29 0.21 6.82% -68.84%
Pfizer 51.40 -0.32 -0.62% 22.82%
PTC Therapeutics 38.21 0.28 0.74% -38.36%
Ultragenyx Pharmaceutical 81.01 -3.43 -4.06% -37.14%
Roche Holding 372.90 4.65 1.26% 21.76%
Sangamo BioSciences 8.72 0.25 2.95% -14.76%
Sarepta Therapeutics 86.02 0.69 0.81% -46.00%
TG Therapeutics 18.04 0.57 3.26% -39.10%
Vertex Pharmaceuticals 206.61 1.39 0.68% -7.92%
Acceleron Pharma 178.75 -0.93 -0.52% 57.43%
Xencor 35.80 0.23 0.65% -14.70%
Zogenix 13.14 0.23 1.78% -37.28%

Indexes Price Day Year
NASDAQ 15787 100.07 0.64% 27.94%
US2000 2272 17.92 0.80% 19.43%

PTC Therapeutics
PTC Therapeutics, Inc. is a science-driven global biopharmaceutical company. The Company is focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. The Company's portfolio pipeline includes several commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focused on the development of new treatments for multiple therapeutic areas, including rare diseases and oncology. The Company has two products, Translarna (ataluren) and Emflaza (deflazacort), for the treatment of Duchenne muscular dystrophy (DMD). It has a pipeline of gene therapy product candidates for rare monogenic diseases that affect the central nervous system (CNS), including PTC-AADC for the treatment of Aromatic L-Amino Acid Decarboxylase (AADC).